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Abstract
Background: Radix Puerariae (Gegen) contains abundant isoflavones in the forms of glycosides and aglycones, such
as daidzein, daidzin and puerarin. This study aims to investigate the intestinal absorbability and mechanism of
these three structurally related isoflavones.
Methods: The bi-directional transport of these three isoflavones in Caco-2 monolayer model was performed to
evaluate their absorbability and involvement of transporters in Transwell. In vitro incubation of daidzin and puerarin
with rat intestinal microvilli preparation was conducted to estimate their potential form of absorption in vivo.
Results: Daidzein demonstrated passive diffusion transport while puerarin did not. Daidzin showed basolateral-to-
apical transport and the absorption extent could be reduced by 50% in the presence of MK571, a multidrug
resistance-associated protein inhibitor (MRP). The in vitro incubation study of daidzin and puerarin indicated that
daidzin was hydrolyzed to daidzein whereas puerarin remained unchanged.
Conclusion: While daidzein was transported more efficiently, puerarin was resistant to intestinal hydrolysis and
inefficiently transported across intestinal epithelium. Daidzin demonstrated a low intestinal absorbability due to a
significant efflux transport mediated by MRPs. Daidzin was likely to be hydrolyzed by intestinal microvilli and
subsequently released daidzein for intestinal absorption.
Background
Radix Puerariae, a Chinese medicinal plant, contains
three major isoflavones, namely daidzein, daidzin and
puerarin (Figure 1). Daidzin, which was reported to inhi-
bit aldehyde dehydrogenase-2 (ALDH-2) in isolated
mitochondria, may be useful as an anti-alcohol agent
[1,2]. Puerarin is used to relieve thirst and treat com-
mon cold and neck stiffness due to hypertension [3].
Despite various pharmacological activities reported for
isoflavones, only a few pharmacokinetics studies on the
soybean isoflavones were reported [4,5]. Izumi et al.
found that the absorption rate of aglycones were higher
than their corresponding glycosides due to their higher
lipophilicities and smaller molecular sizes [5]. Setchell et
al. indicated that isoflavone glycosides such as daidzin
and genistin in the blood sample were barely detectable
whereas a large amount of isoflavone aglycone and its
conjugated glucuronides were found in blood [6].
Another study suggested that the in vivo bioavailability
of isoflavone glycosides could be enhanced by increasing
the activities of beneficial intestinal bacteria which were
capable of hydrolyzing the glycosides to their corre-
sponding aglycones [7]. Moreover, isoflavones were
reported to undergo enterohepatic recirculation [8,9],
suggesting that certain transport mechanisms other than
passive diffusion may involve in the absorption of isofla-
vones such as multi-resistance protein (MRP) transpor-
ters [10,11]. On the other hand, puerarin may exhibit
different pharmacokinetics because the intestinal b-glu-
cosidase is reported to be weakly effective in catalyzing
the hydrolysis of puerarin like C-glucoside [12]. Yasuda
et al. [12] showed that puerarin was detected in the
blood and that conjugated metabolites of both puerarin
and daidzein were found in urine, suggesting that puer-
arin could be absorbed in its intact form while part of it
could be hydrolyzed to daidzein before being absorbed
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in the gastrointestinal tract. Kim et al. demonstrated the
intestinal bacterial mediated biotransformation of puer-
arin to daidzein [13].
Previous findings focused on the intestinal bacterial
hydrolysis during the absorption of isoflavone glycosides.
For in vivo studies, Caco-2 cell monolayer model [14]
was chosen for the investigation of the absorption
mechanisms of the three isoflavones and the comparison
of absorption between the glycoside and its aglycone in a
controlled environment. This study aims to investigate
the intestinal absorption mechanisms of daidzin, daidzein
and puerarin by using human Caco-2 cell monolayer
model as well as in vitro rat microvillus hydrolysis model.
Methods
Chemical and reagents
Daidzin was purchased from Fluka Chemie (Germany).
Puerarin and daidzein were provided by DH Chen from
the Institute of Medicinal Plant Development, Chinese
Academy of Medical Sciences, China. Analytical-graded
acetonitrile (ACN) were purchased from Riedel-de Haën
(Germany). Sodium dihydrogenphosphate dihydrate was
purchased from BDH Chemical (UK). Analytical grade
dimethyl sulphoxide (DMSO) was from Lab-Scan Analyti-
cal Sciences (Thailand). Phosphate buffered saline tablets
were purchased from Sigma Chem Co (USA). MK571 was
supplied by Biomol Research Laboratory (USA).
Caco-2 human colon carcinoma cell line was obtained
from American Type Culture Collection (ATCC number
HTB37, USA). Dulbecco’s Modified Eagle’s Medium,
fetal bovine serum, nonessential amino acid, L-gluta-
mine and trypsin-EDTA used in cell culture were pur-
chased from GibcoBRM (USA). Transwell® inserts
(sterile Polycarbonate filter) were purchased from Corn-
ing Costar Corporation (USA).
Physicochemical characteristics of the selected
isoflavones
Stability of the selected isoflavones in transport buffer
The transport buffer (PBS+) used in the Caco-2 mono-
layer model was prepared as previously described [15].
Briefly, 20 μg/ml of puerarin and daidzin and 0.5 μg/ml
of daidzein solutions in PBS+ at pH6.8 or pH7.4 were
kept in 37°C water bath. For stability tests at 37°C, sam-
ples were taken at 0, 15, 40, 75, 120 and 180 minutes.
At each time interval, 300 μl of isoflavone solution was
taken and then acidified with 50 μl of 0.425% phospho-
ric acid. All experiments were conducted in triplicates.
The amount of selected isoflavones remained in PBS+
was determined with high-performance liquid chromato-
graphy (HPLC).
Partition coefficients of the selected isoflavones
The aqueous solution (10 ml) containing individual iso-
flavones was mixed with octanol (3 ml). The mixtures
were equilibrated in tube rotator for 24 hours followed
by sampling from the aqueous layers and determining
concentrations of the isoflavones by HPLC. The test was
performed in triplicates for each isoflavone. The parti-
tion coefficients (D) at both pH7.4 and pH 6.8 were
obtained through the following equation:









Bidirectional transport studies of the selected isoflavones
in the Caco-2 monolayer model
Caco-2 cell culture
The Caco-2 cells were cultured and seeded in the
Transwell® inserts (24 mm, 0.4 μm pore size, 4.71 cm2,
polycarbonate filter) according to our previous study
[15]. Cells used for the current study were from passage
35-40. The transport experiments were carried out at
23-25 days after seeding.
Apical-to-basolateral (A®B) transport studies
Upon removal of culture medium, the Transwells® were








Figure 1 Chemical structures of the three selected isoflavones.
A Daidzin; B Daidzein; C Puerarin.
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1.5 ml of the isoflavone solution was loaded to the api-
cal (donor) chamber of the Transwell® while 2.6 ml of
blank PBS+ was loaded to the basolateral (receiver)
chamber. For the transport study of daidzein, 0.5 ml of
the sample was taken from the receiver side at certain
time interval (15, 30, 45, 60 and 90 minutes) followed
by replacing with an equal volume of blank PBS+. Sam-
ples were also obtained from the donor side at 90 min-
utes. For the transport studies of puerarin and daidzin,
samples were taken at 30, 60, 90, 120, 150 and 180 min-
utes from receiver side and at 180 minutes from the
donor side. All Caco-2 transport studies were performed
at least in triplicates.
Basolateral-to-apical (B®A) transport studies
Procedure was similar to the A®B transport studies
except for the donor side and the receiver side was
reversed. Loading solution (2.6 ml) was added into the
basolateral side and 1.5 ml of the blank PBS+ was added
to the apical side. Samples were taken from the receiver
(apical) side at the same time points and at the end of
the experiment from the donor (basolateral) side as
mentioned for the A®B studies. The studies were also
performed at least in triplicates.
Basolateral-to-apical transport studies of the selected
isoflavones in the presence of MK571
The study was performed only for isoflavones that had
shown a favorable B®A transport in the bi-directional
transport studies. As demonstrated in our previous
study [15], MK571 is a MRP inhibitor. To investigate
the influence of MRP on the efflux transport of the
selected isoflavones, we preloaded 1.5 ml of MK571 (50
μM) at apical side and 2.6 ml of MK571 (50 μM) at the
basolateral side respectively. The B®A transport experi-
ments of the selected isoflavones in the presence of
MK571 (50 μM) in the both apical and basolateral
chambers were then performed following the method
described above. The studies were performed in
triplicates.
Potential hydrolysis of daidzein glycosides during
intestinal absorptions
Male Sprague-Dawley rats, supplied by and bred at the
Laboratory Animal Service Center at The Chinese Uni-
versity of Hong Kong, were housed in an air-condi-
tioned room under a 12/12-hour light/dark cycle. The
experiment was conducted after being approved by the
Animal Ethics Committee of The Chinese University of
Hong Kong. The rat intestinal microvilli preparations
(protein content: 0.43 mg/ml) were collected as pre-
viously described [16] and incubated with daidzin and
puerarin (50 μM) at 37°C for two hours before we
added the same volume of ice-cold methanol to termi-
nate the reaction.
Sample treatment and analysis
Samples obtained in the Caco-2 transport studies were
acidified with 0.425% phosphoric acid at a sample to
acid ratio of 150:25 (v/v). An aliquot of acidified samples
(100 μl) was injected into the HPLC for the measure-
ment of the isoflavone concentrations. Waters 2695
separation modules and Waters 996 photodiode array
detector were used in the HPLC analyses of the Caco-2
samples. A reversed-phase column (100 × 4.6 mm 5μ
Apex ODS Symm, Jones Chromatography, USA)
equipped with a guard column (7.5 × 4.6 mm 5μ Spheri-
sorb® ODS-2 C18, Waters, USA]) was used for the ana-
lyses of all three isoflavones. In order to shorten
sample-running time, three separated HPLC methods
were used for each isoflavone.
For the analysis of daidzein, an isocratic mobile phase
of 27% ACN in 0.025 M phosphate buffer (pH2.5) at a
flow rate of 1 ml/min was used for the analysis of daid-
zein. For the analysis of puerarin, a gradient mobile
phase consisting of ACN and 0.025 M phosphate buffer
(pH2.5) was used. The gradient program started with a
2-minute run of 10% ACN and 90% of phosphate buffer,
then the percentage of ACN was increase to 15% in 10
minutes followed by a decrease of 10% in the following
three minutes and maintaining the percentage for
another five minutes. Similar to puerarin, a gradient
mobile phase containing ACN and 0.025 M phosphate
buffer (pH2.5) was used for the detection of daidzin.
The elution started with 18% ACN and 82% buffer, fol-
lowed by an increase of the proportion of ACN to 30%
in the next two minutes and then maintaining for three
minutes before returning to the initial condition in two
minutes and remaining with the same elution condition
for another four minutes. Daidzein was detected at 300
nm whereas daidzin and puerarin were detected at 250
nm. The detection limits of the selected isoflavones
were the lowest concentration of the compounds that
could produce peak height three times greater than that
of the background noise. The concentrations of pre-
pared isoflavone standard solutions ranged from 0.0125-
1 μg/ml.
Samples from the in vitro incubation studies were cen-
trifuged at 16,000 × g (Eppendorf, Germany) for five
minutes; 50 μl of the supernatant of the samples were
obtained and injected into the HPLC for analysis. In
order to monitor daidzin, puerarin and daidzein in a
single run for the samples from the hydrolysis study, we
modified the above HPLC method for simultaneous
detection of the three compounds. The analytes were
separated with an HPLC column (BDS reversed phase
column, 25 cm × 4.6 mm id; 5 μm particle size, Thermo
Hypersil, UK) and eluted by the linear gradient elution
at a flow rate of 1 ml/min. The gradient started with
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95% of water with 0.01% aqueous acetic acid (A) and 5%
of ACN containing 0.01% acetic acid (B), changed line-
arly to 83% A and 17% B in 30 minutes; 70% A and 30%
B in 30-40 minutes; 50% A and 50% B in 40-45 minutes;
and then back to the initial composition in 15 minutes
followed by ten minutes after equilibrium.
Data analysis
The apparent permeability coefficient, Papp (cm/s), was




where dC/dT is the initial slope of the plot of cumula-
tive isoflavone concentrations versus time; V is the
volume of receiver chamber (ml); A is the apparent sur-
face area of the monolayer; Co is the initial concentra-
tion in donor site (μmol/ml). In addition to Papp, the
percentage of recovery was calculated for each transport
study to determine the extent of absence of isoflavone,
which may be due to cell uptake or metabolism of the
selected isoflavones after passing through the Caco-2
cells. It was calculated as follows.
Recovery% = Final amount (in mole) of isoflavone in donor and receptor side/Initial
amount (in mole) of isoflavone in donor side
The reported values are expressed as mean ± standard
deviation (SD). Unpaired Student’s t-test was used to
evaluate the statistically significance of difference
between two groups. A value of P < 0.05 was considered
statistically significant for all tests.
Results
HPLC analysis
The calibration curves of daidzein, puerarin and daidzin
were linear throughout the studied concentration range
with correlation coefficients greater than 0.999. The
detection limits of these three isoflavones were 50 ng/ml
for daidzein, 25 ng/ml for daidzin and 12.5 ng/ml for
puerarin. Inter-day verification was conducted with
three sets of calibration curve determined at different
days. Intra-day verification was performed on three sets
of data measured on the same day. Analyses of all isofla-
vones showed percentage deviation of less than 10% for
all concentrations tested.
Physicochemical characteristics of the selected
isoflavones
After three hours of incubation at pH6.8/pH7.4, 95.50 ±
0.84%/97.73 ± 3.43%, 105.00 ± 2.72%/106.74 ± 4.20%
and 108.66 ± 2.16%/108.11 ± 5.21% of daidzein, puerarin
and daidzin remained respectively, indicating that the
selected isoflavones were considerably stable in PBS+
under all pH conditions and suitable for the Caco-2
transport studies. To mimic the physiological pH of
human intestine, we chose pH6.8 for the transport
studies.
The D of the isoflavones at pH7.4 was 0.06 ± 0.02 for
puerarin, 0.80 ± 0.03 for daidzin and at least 2.58 ± 0.02
for daidzein which corresponded to the order of their
lipophilicities, ie daidzein > daidzin > puerarin. The D at
pH 6.8 was also measured which was greater than 2.58
± 0.02, 0.34 ± 0.03, -0.42 ± 0.15 for daidzein, daidzin,
puerarin respectively. The order of lipophilicities of the
studied isoflavones at the two studied pH conditions
was the same.
Bi-directional transport studies of isoflavone solutions in
the Caco-2 monolayer model
The loading concentrations for the three isoflavones
solutions in Caco-2 transport studies were 18.25 ± 0.11
μg/ml for daidzein, 22.10 ± 1.11 μg/ml for puerarin and
18.55 ± 0.34 μg/ml for daidzin. The results of bi-direc-
tional transport studies of the three selected isoflavones
are summarized in Table 1. Daidzein was detectable in
receiver chambers 15 minutes after being loaded with
similar Papp and percentage recoveries for both direc-
tional transport studies. On the other hand, puerarin
did not demonstrate passive diffusion either in 120 min-
utes after apical loading or 60 minutes after basolateral
loading in the Caco-2 monolayer model. The cumulative
concentrations of puerarin found at 180 minutes in the
receiver sides was 0.043 ± 0.006 μM after apical loading
and 0.12 ± 0.02 μM after basal loading with the percen-
tage of recoveries above 89%. In summary, from both
directional transport studies, puerarin was barely detect-
able in the receiver sides (only around 0.3% of puerarin
permeable through the Caco-2 monolayer). Daidzin
showed a significant difference (t = 24.5, P < 0.0001)
between its two directional transport studies with unde-
tectable daidzin in receiver chamber from all sampling
Table 1 Bi-directional transport of the selected isoflavones in Caco-2 monolayer model
Isoflavones Apical to basolateral Basolateral to apical
Papp (cm/s) Recovery (%) Papp (cm/s) Recovery (%)
Daidzein 34.2 ± 7.06 × 10-6 83.12 ± 5.74 38.6 ± 1.81 × 10-6 83.96 ± 14.1
Puerarin ND 88.91 ± 7.03 ND 92.73 ± 8.09
Daidzin ND 92.94 ± 1.77 5.30 ± 0.20 × 10-7 99.17 ± 2.55
The data are expressed as mean ± SD (n = 3). ND: not detectable
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times after apical loading and a more efficient transport
after basolateral loading. Therefore, carrier mediated
transport of daidzin from B®A side was suggested and
the inhibition transport study on daidzin using MK571
was performed afterwards.
B®A transport study of daidzin in the presence of MK571
Figure 2 shows the cumulative concentration versus
time profiles for the basolateral-to-apical transport of
daidzin in the absence and presence of MK571. In the
presence of MK 571, daidzin was only detectable in the
receiver chamber starting from 90 minutes after being
loaded. The cumulative concentration of daidzin in the
receiver chamber was 0.41 ± 0.02 μM at 180 minutes,
which was about 50% lower than that without MK571.
The percentages of recovery of daidzin for these trans-
port studies were all above 90%.
Hydrolysis of daidzin and puerarin during intestinal
absorptions
As shown in Figures 3 and 4, after incubation with rat
intestinal microvilli preparations for two hours, the
majority of puerarin remained unchanged (Figure 4)
whereas daidzin (Figure 3) were completely hydrolyzed
to daidzein with no detectable daidzin in the incubation
medium.
Discussion
Daidzein, puerarin, and daidzin, the three selected isofla-
vones for this study, have a common isoflavone nucleus
and structurally exist as aglycone, C-glucoside and O-
glucoside respectively. The results of this study show
that these three compounds transported differently
across the Caco-2 cell monolayer, thereby exhibiting dif-
ferent transport mechanism when absorbed through the
human gastrointestinal tract. The physicochemical tests
performed on the three compounds provided informa-
tion on the properties of the selected isoflavones, which
possibly affected their transport through the Caco-2 cell
monolayer.
As indicated by the rankings of D at both pH6.8 and
pH7.4, there was a large difference (over 200-fold, P <
0.0001) in the D between isoflavone aglycone and its
glycosides. Daidzein was the most lipid-soluble one with
the concentration of daidzein barely detectable in the
aqueous layer. Therefore, the log P and log D values of
daidzein were estimated based on the HPLC detection
limit of it. Daidzin demonstrated a moderate log P value
with a slight preference in octanol. Puerarin had the
lowest log P value among the three, suggesting its pre-
ference in water.
The bi-directional transport studies of the three
selected isoflavones in the Caco-2 monolayer model
found that the Papp values of daidzein were the
highest, with both Papp A to B and Papp B to A greater
than 10-5cm/s. Moreover, the Papp value of daidzein
found in both directional transport studies were simi-
lar, indicating that the compound was likely to be
mainly transported across the monolayer by passive
diffusion. The percentage of recovery for daidzein after
transport studies was about 83% for both directional
transport studies, which was lower than that obtained
from puerarin and daidzin. Since the three isoflavones
were all confirmed to be stable in PBS+ under the
experimental condition, the cell uptake and intracellu-
lar metabolism of daidzein may contribute to its rela-
tively lower recovery, which was also suggested by
Murota et al. [17].
In this study, puerarin was poorly transported through
the Caco-2 cell monolayer with its concentration in
receiver chamber not being detectable until two hours.
Only about 0.3% of puerarin passed through the mono-
layer in directional transport studies, indicating that the
two directional permeabilities of puerarin were similar
and puerarin likely passed through the monolayer with
the passive diffusion pathway. Assuming that puerarin
was mainly absorbed in the gut by passive diffusion, we
think the role of intestinal bacteria in breaking down it
into daidzein may be important. However, no hydrolysis
of puerarin was shown by Yasuda et al. [12] and this
study. The absorption mechanism of puerarin was prob-
ably different from that of the other studied isoflavones.
This study only established the preliminary absorption
profile of puerarin, further investigations are needed to
study the relationship between absorbed puerarin and
its pharmacological effects.
Daidzin had a different transport profile from the
other two isoflavones with a significant efflux medicated
by MRP, which was consistent with Vaidyanthan et al
[11]. As multidrug resistance-associated protein 2
(MRR2) was responsible to transport various com-
pounds containing O-glucuronides including estradiol
17b-D-glucuronide [18], it was also possible to mediate
the efflux transport of daidzin, due to their structural
similarity.
Two factors may contribute to the absorption differ-
ences between daidzein and daidzin. Izumi et al. [5]
suggested that daidzin is a more hydrophilic and bigger
molecular in molecular size which may affect its absorp-
tion through passive diffusion pathway. Another factor
was the efflux of daidzin, which would prevent it from
being transported across the intestinal wall. These two
factors may explain the different findings in the absorp-
tion of daidzein and daidzin. On the other hand, as
active transport mechanisms could not be found in the
transport of puerarin, the limited absorption of puerarin
was likely due to its large molecular size and high
hydrophilicity. Between the absorptions of daidzin and
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Figure 2 Basolateral-to-apical transport of daidzin in the absence and presence of MK 571, the MRP inhibitors.
Figure 3 The HPLC-UV chromatograms of daidzin before and after incubations with rat intestinal microvilli preparations. I.S.: internal
standard.
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puerarin, daidzin showed a significant B®A efflux
whereas puerarin did not, indicating that puerarin was
unlikely to be the substrate of MRP transporters.
The incubation with rat intestinal microvilli prepara-
tions demonstrated that daidzin could release its agly-
cone daidzein while puerarin was relatively stable during
their absorption processes in. Due to the high polarities
and poor A®B permeabilities of daidzin and puerarin, it
was not likely that these two glycosides of daidzein
could be absorbed directly at small intestine in vivo.
However, daidzin could be absorbed after hydrolysis at
small intestine to daidzein which could be absorbed due
to its high lipophilicity.
Conclusion
While daidzein was transported more efficiently, puer-
arin was resistant to intestinal hydrolysis and ineffi-
ciently transported across intestinal epithelium. Daidzin
demonstrated a low intestinal absorbability due to a sig-
nificant efflux transport mediated by MRPs. Daidzin was
likely to be hydrolyzed by intestinal microvilli and sub-
sequently released daidzein for intestinal absorption.
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